Final results of CALGB 50803 (Alliance): A phase 2 trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma
- Citation:
- Hematol Oncol vol 35 (suppl S2) 51
- Meeting Instance:
- ICML 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2762
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Peter Martin Sin-Ho Jung Brandy Pitcher Nancy Bartlett Kristy Blum Thomas Shea Jia Ruan Scott Smith John Leonard Bruce Cheson
- Networks:
- CAPITAL, IL017, LAPS-MO011, LAPS-NC007, LAPS-OH007, NY018
- Study
- CALGB-50803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: